Riskpilot← Back to searchSign inGet full accessLEGEKLINIKK1 AS
ASActiveOrg 820372832Alaskasvingen 13, 9013 TromsøEngineering activities and related technical consultancy · NACE 7112Est. 20180 employees
Revenue 2024
NOK 0
EBITDA margin
—
-2949% vs 2023
Equity ratio
69.6%
Financial strength
Net profit 2024
NOK -65K
-2270% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -84K | -2949% |
| Net profit | NOK -65K | -2270% |
| Total assets | NOK 205K | +35% |
| Equity | NOK 142K | +1745% |
| Employees | 0 | — |
Legal name
LEGEKLINIKK1 AS
Org number
820372832
Legal form
Aksjeselskap
NACE code
7112 · Engineering activities and related technical consultancy
Founded
12. februar 2018
Share capital
NOK 72 642
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap. Styrets leder og ett styremedlem i fellesskap.
Company purpose
Skape og utvikle nye helsetjenester og videreutvikle eksisterende helsetjenester og andre produkter som naturlig faller sammen med dette og tilby og yte disse tjenester. Herunder å delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender.
Address
Alaskasvingen 13, 9013 Tromsø
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 27 | 7 | 24 | 2 | 0 |
| Staff expenses | −0 | −16 | −0 | −0 | −0 |
| EBITDA | −81 | −119 | −49 | −3 | −84 |
| Depreciation & amort. | −24 | −0 | −0 | −0 | −0 |
| EBIT | −105 | −119 | −49 | −3 | −84 |
| Net financials | −0 | 0 | −0 | 0 | 19 |
| Profit before tax | −105 | −119 | −49 | −3 | −65 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −105 | −119 | −49 | −3 | −65 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 140 | 184 | 155 | 151 | 205 |
| Equity | −69 | 43 | 10 | 8 | 142 |
| Long-term debt | 0 | 76 | 76 | 76 | 0 |
| Short-term debt | 209 | 65 | 68 | 68 | 62 |
| Total debt | 209 | 141 | 144 | 144 | 62 |
EBITDA margin
-8412800.0%
This company
15.8%
Market median
-53245670% vs market
20202024
Equity ratio
69.6%
This company
38.2%
Market median
+82% vs market
20202024
Return on equity
-45.9%
This company
18.4%
Market median
-349% vs market
20202024
Net profit margin
-6537800.0%
This company
8.1%
Market median
-80713680% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.44×
This company
0.62×
Market median
+29% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 34% | 34% | 2022 | |
| Company | 33.89% | 33.89% | 2022 | |
| Company | 27.28% | 27.28% | 2022 | |
| Company | 3.03% | 3.03% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Alvvat As
LEGEKLINIKK1 AS Board members of LEGEKLINIKK1 AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Odd Petter Elvenes | Board of Directors | 0 companies |
| Berit Merete Nystad Eskonsipo | Chairman | 0 companies |